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INTRODUCTION
Retinoblastoma is the most common in-
traocular malignancy of childhood. Approxi-
mately, 1 in 200,000 children under 15 years old
is affected. One third of these children have a
bilateral and/or multifocal intraocular retino-
blastoma1). Such patients are referred to as hav-
ing hereditary retinoblastoma, as they possess a
germline mutation in one allele of the RB1
gene2). Retinoblastoma is commonly found early
childhood and the median age of unilaterally af-
fected children is 25 months: yet bilaterally af-
fected patients are diagnosed substantially ear-
lier at the age of 15 months3). However, retino-
blastoma found in the first month of life is un-
usual and rare.
Here, we report a newborn female patient
with bilateral retinoblastoma. Her intraocular tu-
mor was already group V of the Reese
Ellsworth classification at the age of 2 weeks.
CASE REPORT
A few days after birth, an abnormal pupil-
lary reflex of the left eye of a newborn female
baby was noticed by her parents. There was no
family history of ocular tumors. On the initial
examination at Adachi ganka clinic, a leukokoria
was noticed in the left pupil. Examination of the
right eye was unremarkable. Fundus examina-
tion of the left eye revealed a large white mass
occupying more than half of the vitreous cavity
and arising from the posterior pole with vitre-
ous seeding. During several few days, the in-
traocular mass grew and intraocular pressures
(IOPs) of her left eye increased more than 20
mmHg. Then she was referred to Sapporo
Medical University Hospital for further investi-
gation. A CT scan revealed an ovoid mass bulg-
ing into more than half of the vitreous cavity
and accompanied with calcified lesions (Fig. 1).
The lesion was diagnosed as a unilateral retino-
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ABSTRACT
Retinoblastoma is the most common ocular
malignancy in children and is usually found at
the age at 12 years. Diagnosis earlier than the
first month of life is rare. Here we report a new
born female patient with bilateral retinoblas-
toma. Her intraocular tumor was already group
V of the ReeseEllsworth classification at the
age at 2 weeks.
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blastoma, group V, according to the classifica-
tion of Reese and Ellsworth4). Enucleating of the
left eye was performed under general anesthe-
sia. On gross examination the tumor was seen
to occupy more than half space of the vitreous
(Fig. 2). Histopathology of the specimen revealed
that the tumor was an undifferentiated retino-
blastoma, and tumor invasion beyond the lamina
cribrosa was also recognized (Fig. 3). However,
no tumor invasion was detected within the sur-
gically cut edge of the optic nerve. Two new in-
traocular tumors were found within the right
eye on funduscopic examination. The size of
these two tumors were approximately one disk
diameter and they were treated with laser pho-
tocoagulation.
Fig．３
Fig．１ Preoperatively CT scan revealed a large in-
traocular mass with calcification in the right
eye.
Histopathology of the intraocular tumor. Panel A shows tumor invading the vitreous cavity and
panel B depicts the optic nerve invasion. Both specimens were stained by hematoxylineosin. Cal:
calcification, Opt: optic nerve, lam: lamina cribrosa. Scale bar; 0.1 mm.
Fig．２Gross appearance of the enucleated left eye
shows intraocular tumor invading more than
half of the vitreous space.
２２ H．OHGURO et al.
DISCUSSION
Retinoblastoma is the most common pri-
mary intraocular malignant tumor of childhood.
The survival rate of patients with retinoblas-
toma has improved markedly over the last cen-
tury since it was first described (In 1958, Reese5)
reported a 63% 5year survival rate, in 1990s,
the overall 5year survival in many centers ap-
pears to be in the 90% range6)). This improve-
ment in the survival rates is attributed to ear-
lier diagnosis and improved treatment. It is
known that patients with RB1 genetic mutation
are more likely to die of secondary nonocular
tumors that develop at a mean duration of 10
years after the diagnosis of retinoblastoma7).
However, even today, extraocular spread of reti-
noblastoma is associated with a 100% mortality
rate. It has been shown that retinoblastoma me-
tastasizes through hematogeneous dissemina-
tion, lymphatic spread, direct infiltration along
the optic nerve and dispersion through the cere-
brospinal fluid after cells in the optic nerve in-
vade the leptomeninges6,8). It was reported that
the mean age at diagnosis for unilateral retino-
blastoma patients; it is 25 months, whereas for
bilateral retinoblastoma patients it is 15 months
in the United States3). In cases of a known fam-
ily history, children are screened for the disease,
and thus the mean age at diagnosis is less than
1 year at age. Yet, it was demonstrated that the
most common stage of the tumor was Reese
Ellsworth group V and the most common mani-
festing sign was leukocoria despite the diagnosis
within 1 year, or even 6 months of life. Recently,
Abramson et al.9) reported the clinical features
of 46 retinoblastoma patients who were diag-
nosed in the first month of life. They registered
less than 0.003% of entire cohort of 1831 retino-
blastoma patients. Thus this suggests that the
present case of retinoblastoma found in a new
born female is rare. Abramson and their col-
league found in their study that 26 (56%) pa-
tients were initially detected as unilateral retino-
blastoma and 22 out of these (85%) ultimately
developed cancer in the fellow eye, and the inci-
dence of secondary nonocular cancers were
found in 14 patients (54%) during the followup
periods (mean 10.9 years). Therefore, a great at-
tentions should be taken to detect new retinal
tumors and nonocular malignancies in the pre-
sent patient.
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